Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-Q __________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to Commission File Number 001-37795 ________________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number 001-40397 Flora Growth Corp. (Exact name of registrant as specified in its charter) (State or other jurisdi ...

AGNC INVESTMENT CORP. (Exact name of registrant as specified in its charter) _________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34057 Securities Registered Pursuant to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 7373 Wisconsin Avenue, 22nd Floor Bethesda, Maryland 20814 (Address of principal executive offices) (301) 968-9315 (Registrant's telephone number, including area code) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34057 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34057 AGNC INVESTMENT CORP. (Exact name of registrant as specified in its charter) _________________________________________________________ Delaware 26-1701984 (State or Oth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-34057 AGNC INVESTMENT CORP. (Exact name of registrant as specified in its charter) _________________________________________________________ Delaware 26-1701984 (State or Oth ...

[PART I. FINANCIAL INFORMATION](index=3&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The company's consolidated financial statements for the period ended June 30, 2025, show an increase in total assets to **$102.021 billion** from **$88.015 billion** at year-end 2024, primarily driven by an increase in Agency securities and repurchase agreements Consolidated Balance Sheet Highlights (in millions) | Balance Sheet Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | **$102,021** | **$88,015** | | Agency securities, at fair value | $73,232 | $65,367 | | Repurchase agreements (liability) | $69,153 | $60,798 | | **Total Liabilities** | **$91,674** | **$78,253** | | **Total Stockholders' Equity** | **$10,347** | **$9,762** | Consolidated Comprehensive Income Highlights (in millions, except per share data) | Income Statement Item | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | :--- | :--- | | Net Interest Income (Expense) | $162 | $(3) | $321 | $(33) | | Net Income (Loss) | $(140) | $(48) | $(90) | $395 | | Comprehensive Income (Loss) | $(92) | $(66) | $51 | $300 | | Net Income (Loss) per common share - diluted | $(0.17) | $(0.11) | $(0.17) | $0.46 | Consolidated Cash Flow Highlights (in millions) | Cash Flow Item | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $372 | $0 | | Net cash provided by (used in) investing activities | $(9,171) | $(6,479) | | Net cash provided by (used in) financing activities | $8,900 | $6,614 | - The company operates as a single reportable segment, with the Chief Operating Decision Maker (CODM) evaluating performance based on comprehensive income (loss) and managing the portfolio as a whole[117](index=117&type=chunk)[118](index=118&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=26&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management reported significant market volatility in Q2 2025, leading to wider Agency RMBS spreads and an economic loss of **-1.0%** on tangible common equity for the quarter, while maintaining a constructive outlook due to stabilizing spreads and anticipated regulatory reforms - Financial markets experienced significant volatility in Q2 2025, leading to underperformance in Agency RMBS and an economic loss for AGNC of **-1.0%** for the quarter[123](index=123&type=chunk)[128](index=128&type=chunk) - The company maintains a constructive outlook for Agency RMBS due to stabilizing spreads, expected increased bank demand from regulatory reforms, and reduced risk from potential GSE reform[124](index=124&type=chunk)[127](index=127&type=chunk) Key Performance Metrics (Q2 2025) | Metric | Value | | :--- | :--- | | Total Comprehensive Loss per Share | $(0.13) | | Economic Loss on Tangible Common Equity | -1.0% | | Dividends Declared per Common Share | $0.36 | | Decrease in Tangible Net Book Value per Share | $(0.44) | | Net Spread and Dollar Roll Income per Share (Non-GAAP) | $0.38 | Portfolio and Leverage (as of June 30, 2025) | Metric | Value | | :--- | :--- | | Investment Portfolio | $82.3 billion | | Tangible 'at risk' Leverage | 7.6x | | Unencumbered Liquidity | $6.4 billion (65% of tangible equity) | | Hedge Ratio (vs. Repo/TBA) | 89% | [Quantitative and Qualitative Disclosures About Market Risk](index=43&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is primarily exposed to interest rate, prepayment, spread, liquidity, and credit risks, with an estimated duration gap of **0.2 years** as of June 30, 2025, and significant sensitivity to changes in interest rates and mortgage spreads - The company's primary market risks include interest rate, prepayment, spread, liquidity, extension, and credit risks[216](index=216&type=chunk) - The company's estimated duration gap, measuring the difference in interest rate sensitivity between assets and liabilities (including hedges), was **0.2 years** as of June 30, 2025[222](index=222&type=chunk) Interest Rate Sensitivity on Tangible Net Book Value per Share (June 30, 2025) | Change in Interest Rate | Estimated Change in Tangible Net Book Value Per Common Share | | :--- | :--- | | -50 Basis Points | -0.7% | | -25 Basis Points | +0.2% | | +25 Basis Points | -1.2% | | +50 Basis Points | -3.2% | Mortgage Spread Sensitivity on Tangible Net Book Value per Share (June 30, 2025) | Change in MBS Spread | Estimated Change in Tangible Net Book Value Per Common Share | | :--- | :--- | | -25 Basis Points | +13.1% | | -10 Basis Points | +5.2% | | +10 Basis Points | -5.2% | | +25 Basis Points | -13.1% | - As of June 30, 2025, the weighted average projected Constant Prepayment Rate (CPR) for the investment portfolio was **7.8%**, with a **50 basis point** decrease in interest rates projected to increase the CPR to **10.1%**[231](index=231&type=chunk)[232](index=232&type=chunk) [Controls and Procedures](index=47&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of June 30, 2025, with no material changes in internal control over financial reporting during the last fiscal quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of June 30, 2025[244](index=244&type=chunk) - No changes occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting[245](index=245&type=chunk) [PART II. OTHER INFORMATION](index=47&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Legal Proceedings](index=47&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently subject to any material litigation, nor is any material litigation threatened against it, other than routine proceedings arising in the ordinary course of business - As of the report date, the company is not involved in any material legal proceedings[247](index=247&type=chunk) [Risk Factors](index=47&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the risk factors that were previously disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024 - No material changes to risk factors have been identified since the last Annual Report on Form 10-K[248](index=248&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=47&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities during the period - There were no unregistered sales of equity securities in the reported quarter[249](index=249&type=chunk) [Other Information](index=47&type=section&id=Item%205.%20Other%20Information) This section discloses that on May 15, 2025, the company's President and CEO, Peter Federico, adopted a Rule 10b5-1 trading arrangement for the potential sale of up to **137,393 shares** of common stock - On May 15, 2025, President and CEO Peter Federico adopted a Rule 10b5-1 trading plan for the sale of up to **137,393 shares** of common stock[252](index=252&type=chunk) [Exhibits](index=47&type=section&id=Item%206.%20Exhibits) This section provides an index of all exhibits filed with or furnished as part of the quarterly report, including certifications by the CEO and CFO, and documents related to the company's incorporation and bylaws - The report includes an index of exhibits, such as the CEO/CFO certifications required by the Sarbanes-Oxley Act and various corporate governance documents[253](index=253&type=chunk)[254](index=254&type=chunk)[255](index=255&type=chunk)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13412 Hudson Technologies, Inc. (Exact name of registrant as specified in its charter) | New York | 13-3641539 | | --- | --- | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 OR ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _________ to _________ Commission file number 000-21129 AWARE, INC. (Exact Name of Registrant as Specified in Its Charter) Massachusetts 04-2911026 Incorporation or Organ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from__________ to __________ Commission file number: 001-32550 One E. Washington Street, Suite 1400 Phoenix Arizona 85004 (Address of principal exe ...